BC Cancer Research Centre

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion	Erythroplasia, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, erythroplakia, hyperplasia, leukoplakia, mouth disorder, neoplasm, oral cavity carcinoma, oral mucosa leukoplakia, precancerous condition	Active, not recruiting	Phase 2	2026-06-26		NCT02581137
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, lung carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2025-10-07		NCT04931017

Clinical trials